检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:成元元[1] 聂晶晶[1] 李杰[1] 侯金林[2] 张欣欣[3] 宁琴[4] 高秀媛 丁红芳[4] 刘学恩[1] 庄辉[1]
机构地区:[1]100191北京大学医学部微生物系 [2]南方医科大学附属南方医院感染科 [3]上海交通大学医学院附属瑞金医院感染科 [4]华中科技大学附属同济医院感染科 [5]北京宣武区疾病预防控制中心
出 处:《中华肝脏病杂志》2009年第12期896-899,共4页Chinese Journal of Hepatology
摘 要:目的了解我国大城市成年人群甲型肝炎抗体流行率。方法调查北京、上海、武汉、广州4个城市20~88岁当地常住居民2390人,采用微粒子酶免疫分析法检测血清甲型肝炎病毒抗体(抗-HAV IgG)。利用Excel建立数据库,采用SPSS13.0统计软件进行数据分析。结果北京30~39岁年龄组女性抗-HAV IgG阳性率为64.58%(62/96),男性45.57%(36/79),女性抗-HAV IgG阳性率高于男性,Х^2=6.358,P=0.012,差异有统计学意义。北京和广州成人抗-HAV IgG流行率随年龄增加而上升,北京20岁~、30岁~、40-49岁组分别为54.22%(90/166)、56.00%(98/175)和67.18%(88/131),Х^2=4.76,P=0.03,差异有统计学意义;广州20岁~、30岁~、40岁~、50岁~、60~88岁组分别为52.83%(56/106)、52.50%(63/120)、82.46%(94/114)、89.80%(88/98)和96.77%(60/62),Х^2=72.58,P〈0.01,差异有统计学意义。而上海和武汉则未见此趋势。北京、上海、广州和武汉20~39岁人群抗-HAV IgG阳性率分别为55.13%(188/341)、63.93%(429/671)、52.65%(119/226)和78.37%(308/393)。结论4个城市20~39岁年龄组人群抗-HAV IgG流行率较低。建议对城市20~39岁年龄组易感人群进行甲型肝炎疫苗接种。Objective To investigate the seroprevalence of anti-HAV IgG in adults of 4 cities in China. Methods Serum samples were collected from 2390 local residents aged between 20-88 years from Beijing, Shanghai, Wuhan and Guangzhou. The anti-HAV IgG in sera was detected with a microparticle enzyme immunoassay (MEIA). Results The anti-HAV IgG seroprevalence in female of 30-39 years in Beijing (64.58%, 62/96) was higher than that in male (45.57% 36/79)) ( Х^2 = 6.358, P = 0.012). It increased with age in adults of Beijing and Guangzhou. The rates were 54.22 % (90/166), 56.00% (98/175) and 67.18% (88/131) for the 20-, 30- and 40-49 age groups in Beijing (Х^2 = 4.76, P = 0.03); and 52.83% (56/106), 52.50% (63/120), 82.46% (94/114), 89.80% (88/98) and 96.77% (60/62) for the 20-, 30-, 40-, 50- and 60-88 age groups in Guangzhou, respectively (Х^ 2 = 72.58, P 〈 0.01). This trend was not found in Shanghai and Wuhan ( Х^2 = 0.96, 2.99; P = 0.33, 0.08 respectively). The seroprevalence rates of anti-HAV IgG in the 20- 39 age group of B eijing, Shanghai, Guangzhou and Wuhan were 55.13 % ( 188/341 ), 63.93 % (429/671 ), 52.65% (119/226) and 78.37% (308/393), respectively. Conclusion The seroprevalence rates of anti-HAV IgG in young adults aged 20-39 years of the four cities are relatively low, and HAV vaccination should be suggested for the susceptible population of this age group in China.
分 类 号:R181[医药卫生—流行病学] R51[医药卫生—公共卫生与预防医学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.17.74.181